在残留86的特定位点PEGylation改善了干扰素α-2b的药用动力学特性
Mahdiyeh Alsadat Alboshokeh1, Soraya Mirshekar2, Mohammad Hossein Hedayati3
1Department of Biochemistry, North Tehran unit, Islamic Azad University, Tehran, Iran.
干扰素α-2b在threonine 86 (IFN_T86C) 的特定位点PEGylation增强了其药理动力学特性. 这一策略提高了治疗蛋白质的稳定性和有效性,尽管需要进行更长期的研究.
科学领域:
- 生物化学 生物化学
- 蛋白质工程是指蛋白质的工程.
- 药理学 药理学是指药理学的学科.
背景情况:
- 干扰素α-2b (IFN) 的半衰期很短,这限制了其治疗用途.
- 基化延长IFN循环时间,但可以降低其活性.
- 特定站点的PEGylation提供了一种改善IFN结合物的策略.
研究的目的:
- 探索干扰素的囊类同类物用于特定位点的PEGylation.
- 评估PEGylated干扰素变体的药理动力学特性.
- 为了优化治疗蛋白质的有效性和稳定性.
主要方法:
- 在体中识别氨酸替代的表面暴露残留物 (Glu78,Thr86).
- 局部导向的突变发生,基因合成,克隆和表达在大肠杆菌.
- 蛋白质净化,生物活性测定,PEGylation用5kDa的甲基PEG马莱胺,和大鼠的药物动力学评估.
主要成果:
- IFN_T86C保留了83%的本地IFN活动,而IFN_E78C显示了大量的活动损失.
- 基化IFN_T86C (PEG5-IFN_T86C) 在老鼠中表现出改善的药理动力学特性.
- 基化导致生物活性略有降低,但稳定性增强.
结论:
- 在86位的PEGylation显著改善了干扰素的早期药理动力学特性.
- 战略性氨基酸修饰和PEGylation对于优化治疗蛋白质至关重要.
- 需要进一步研究使用更高分子量或分支PEG的长期稳定性.
更多相关视频
08:14Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
相关概念视频
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Production of Pharmaceuticals
Inhibitors of Viral Protein Synthesis
